A$0.38 intraday DAI.AX Decidr AI ASX 07 Feb 2026: AI earnings catalyst

DAI.AX stock is trading at A$0.38 intraday on the ASX on 07 Feb 2026, down 5.00% from yesterday. This price move follows heavier volume at 1,705,832 shares, about 1.84x the average. Investors are watching an upcoming earnings announcement on 13 Feb 2026 and AI-business signals that could shift sentiment quickly.

DAI.AX stock intraday price and volume

The main fact is the intraday quote of A$0.38 on ASX. The stock opened at A$0.40, hit a day low of A$0.34 and a day high of A$0.40. Volume is 1,705,832 versus an average of 893,799, giving a relative volume of 1.84 which supports today’s move.

Valuation and financials for Decidr AI Industries (DAI.AX)

Decidr AI Industries shows a market capitalisation of A$121.20M and EPS of A$0.31, producing a trailing PE of 1.23. Price sits below the 50-day average of A$0.56 and 200-day average of A$0.58, signalling short-term weakness versus longer-term averages. Key ratios show elevated price-to-sales at 62.60 and price-to-book at 16.18, reflecting thin revenue relative to market value.

Meyka AI rates DAI.AX with a score out of 100 and forecast

Meyka AI rates DAI.AX with a score of 62.97 out of 100 (Grade B, Suggestion: HOLD). This grade factors in S&P 500 and sector comparisons, industry metrics, financial growth, key ratios, forecasts and analyst consensus. Meyka AI’s forecast model projects a monthly price of A$0.13 and a quarterly figure of A$3.86. Versus the current A$0.38, those imply changes of -65.79% and +915.79% respectively. Forecasts are model-based projections and not guarantees.

Catalysts, upcoming earnings and sector context

The immediate catalyst is an earnings announcement on 13 Feb 2026 which could validate the company’s AI platform progress. The business mixes Australian beauty and nutraceuticals with a software platform, creating execution risk and optionality. The Technology sector on ASX has averaged higher valuations; sector performance is mixed, so DAI.AX faces both sector tailwinds and short-term rotation risk.

Technical outlook, price targets and analyst context

Short-term technicals show support at A$0.34 and resistance near the 50-day mean at A$0.56. A conservative price target for near-term recovery is A$0.55, implying an upside of +44.74%. A bullish target tied to the year high is A$1.14, implying +200.00% upside. No consensus price target is published; traders should treat targets as scenario levels not forecasts.

Trading strategy for AI stocks and DAI.AX news flow

For AI-focused investors, DAI.AX combines platform upside with consumer product revenue. Consider position sizing that limits downside given high price-to-sales and thin liquidity. Monitor volume spikes, the 50-day crossover, and the 13 Feb 2026 earnings release. Use stop-loss discipline and reassess after the results and any revenue guidance updates.

Final Thoughts

DAI.AX stock is trading at A$0.38 on the ASX on 07 Feb 2026, with heavier-than-normal volume and a 5.00% intraday decline. Valuation metrics are mixed: a low trailing PE of 1.23 and an EPS of A$0.31 sit alongside high price-to-sales and price-to-book multiples. Meyka AI’s model gives divergent short-term outputs — a monthly projection of A$0.13 and a quarterly projection of A$3.86 — showing model sensitivity to different input scenarios. Practical near-term price targets are A$0.55 (base case) and A$1.14 (bull case). Key catalysts are the 13 Feb 2026 earnings release and AI-platform updates. Investors should weigh the company’s technology optionality against current valuation and liquidity, and use risk-managed positions. Meyka AI provides this analysis as an AI-powered market analysis platform; grades and forecasts are not guarantees and do not constitute financial advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.